Important pharmacy news and late-breaking industry information updated daily.
FDA issued on Monday an emergency use authorization (EUA) for bamlanivimab (Eli Lilly), an investigational monoclonal antibody therapy, for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.
On October 30, FDA posted a list of essential medicines, medical countermeasures, and critical inputs following an August 6 executive order that required it to do so.
CVS Health Corp. has tapped Karen Lynch to succeed retiring CEO Larry Merlo, a pharmacist by trade who has led the company for the past decade. Lynch, who currently heads the company's Aetna insurance division, is scheduled to take the helm on February 1, which will make CVS the largest firm by revenue to have a female CEO.
The Associated Press reported on October 14 that a survey it conducted with the NORC at the University of Chicago showed that just 22% of Black respondents said they plan to get the COVID-19 vaccine when it becomes available. Black Americans have been disproportionately hard-hit by the virus. Their hesitancy is a hurdle the pharmacy and medical professions must acknowledge and overcome by earning trust.
Four companies that made or distributed prescription opioid analgesics have reached a tentative $26 billion settlement with counties and cities that sued them for damages in the largest federal court case in U.S. history.
The United States set a one-day record for new coronavirus cases on Wednesday with 104,004 new infections. The previous U.S. record for new cases in a day was 100,233 on October 30, the highest ever reported by any country in the world. Eighteen states reported record numbers of patients hospitalized with COVID-19.
Although they deny any wrongdoing, McKesson said it and rival distributors AmerisourceBergen and Cardinal Health are now facing $21 billion in settlement costs for their alleged role in the U.S. opioid crisis.
Despite APhA’s concerns that compliance with certain Drug Supply Chain Security Act (DSCSA) requirements undermines pandemic response efforts, FDA has confirmed that “dispensers,” including pharmacies, must meet a requirement that goes into effect on November 27, 2020. APhA and pharmacy partners had requested that FDA delay enforcement of certain portions of the DSCSA—also known as “track and trace”—mandate. Learn more about DSCSA.
CDC has added pregnancy to the list of conditions that elevate the risk of morbidity and mortality in COVID-19 patients.
Ibuprofen was associated with better fever reduction and less pain than acetaminophen when used to lower fever and associated pain in infants and toddlers, according to a new study published in JAMA Network Open.